FIELD: medicine, pharmacology, pharmacy. SUBSTANCE: invention relates to a pharmaceutical composition for oral administration. The composition comprises a carrier and dopamine agonist as an active component. The composition is presented as quickly dispersing medicinal form designating for rapid release of an active component in the mouth cavity. Invention proposes also compositions that comprise additionally an antiemetic agent and/or opioide antagonist. Except for, the invention proposes a process for preparing such compositions, the use of such compositions for treatment and/or estimation of Parkinson's disease development and therapeutic products and sets for administration of dopamine agonist and combined administration of dopamine agonist and an antiemetic agent and/or opioide antagonist. Invention provides decrease of undesirable peripheral effects. EFFECT: improved properties of compositions. 26 cl, 2 dwg, 17 tbl
Title | Year | Author | Number |
---|---|---|---|
MEDICINAL FORMS AND METHOD OF TREATMENT OF MALE ERECTILE FUNCTION | 1998 |
|
RU2204413C2 |
PHARMACEUTICAL COMPOSITIONS FOR TREATING PARKINSON'S DISEASE | 2009 |
|
RU2540470C9 |
COMPOSITIONS FOR TREATING PARKINSON'S DISEASE | 2008 |
|
RU2484823C2 |
GELATIN-FREE RAPIDLY DISPERSING MEDICINAL FORMULATION | 2000 |
|
RU2242968C2 |
IONTOPHORETIC ROTIGOTINE DELIVERY IN TREATMENT FOR PARKINSON'S DISEASE | 2003 |
|
RU2339372C2 |
IONOPHORETIC DELIVERY OF ROTIGOTINE FOR TREATMENT OF PARKINSON DISEASE | 2008 |
|
RU2478383C2 |
PHARMACEUTICAL COMPOSITION FOR TREATING, PREVENTING OR RELIEVING MOVEMENT DISORDERS AND ITS APPLICATION | 2011 |
|
RU2611376C2 |
ORAL PHARMACEUTICAL COMPOSITION SUITABLE FOR IMPROVING EFFECTIVENESS OF TREATMENT OF MOTOR DISORDERS | 2013 |
|
RU2670272C2 |
ORGANIC COMPOUNDS | 2017 |
|
RU2743513C2 |
ORGANIC COMPOUNDS | 2018 |
|
RU2777366C2 |
Authors
Dates
2002-09-20—Published
1996-08-16—Filed